Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

  • Home
  • /
  • Genomic Valley
Join Channel
Consolidated Standalone

Genomic Valley

₹48.6 0.9 | 1.8%

Market Cap ₹15 Cr.

Stock P/E 977.4

P/B 3.8

Current Price ₹48.6

Book Value ₹ 12.8

Face Value 10

52W High ₹108.2

Dividend Yield 0%

52W Low ₹ 39.5

Edit Ratio

Genomic Valley Research see more...

Overview Inc. Year: 1994Industry: Agriculture

Genomic Valley Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Genomic Valley Quarterly Results

#(Fig in Cr.) Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 1 1 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 1 1 0 0 0 0 0 0 0 0
Total Expenditure 1 0 0 0 0 0 0 0 0 0
Operating Profit 0 1 0 0 0 -0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 -0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -1 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 1 0 0 0 -0 0 0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax -1 1 0 0 0 -0 0 0 0 -0
Adjustments 0 0 -0 -0 -0 -0 0 0 -0 0
Profit After Adjustments -1 1 0 0 0 -0 0 0 0 -0
Adjusted Earnings Per Share -2.8 3.2 0.1 0.1 0.1 -0.1 0.4 0.5 0.5 -0.3

Genomic Valley Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 0 0 0 0 1 1 1 0 0 3 0 0
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 1 1 1 1 0 0 3 0 0
Total Expenditure 0 0 1 1 0 1 0 0 0 2 0 0
Operating Profit 0 0 -0 -0 0 0 1 -0 -0 1 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -0 0 0
Profit Before Tax 0 -0 -0 -0 0 0 0 -1 -0 1 0 0
Provision for Tax 0 -0 -0 -0 0 0 -0 0 0 0 -0 0
Profit After Tax 0 -0 -0 -0 0 0 0 -1 -0 1 0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 -0 -0 -0 0 0 0 -1 -0 1 0 0
Adjusted Earnings Per Share 0 -0 -1.1 -0.2 0.1 0.8 0.9 -1.8 -0 2.1 0 1.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -100% 0% -100% 0%
Operating Profit CAGR -100% 0% 0% 0%
PAT CAGR -100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -3% 12% 28% NA%
ROE Average 0% 7% 3% 1%
ROCE Average 0% 7% 5% 2%

Genomic Valley Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 6 6 6 4 5 5 5 4 3 4 4
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 1 1 1 1 1 1 2 0 0 0
Other Non-Current Liabilities 0 -0 -0 -0 0 1 1 1 1 0 0
Total Current Liabilities 1 1 1 1 1 0 1 1 0 1 1
Total Liabilities 7 7 7 6 7 7 8 8 4 4 4
Fixed Assets 3 3 3 4 4 4 4 6 2 0 0
Other Non-Current Assets 0 1 3 2 2 3 3 2 1 2 1
Total Current Assets 3 3 0 0 0 0 0 0 1 3 3
Total Assets 7 7 7 6 7 7 8 8 4 4 4

Genomic Valley Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 1 1 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 0 0 -1 0 1 -1 0 1 -2 -1 -0
Cash Flow from Investing Activities 0 -1 1 -0 -1 0 -0 -2 4 2 -0
Cash Flow from Financing Activities 0 0 0 0 0 1 0 0 -2 -1 0
Net Cash Inflow / Outflow 0 -1 -0 0 -0 0 -0 -0 -0 0 -0
Closing Cash & Cash Equivalent 1 0 0 0 0 0 0 0 0 0 0

Genomic Valley Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 0 0 0 0 0 0 0.94 -1.83 -0.03 2.12 0.05
CEPS(Rs) 0.02 -0 -0.93 -0.08 0.36 1.4 1.52 -1.21 0.25 2.15 0.05
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0 0 0 0 0 0 16.52 14.69 9.42 11.55 11.6
Core EBITDA Margin(%) 13.1 -149.51 -406.62 -23.19 16.98 42.24 65.4 -65.57 -534.82 32.38 9.32
EBIT Margin(%) 23.09 63.1 -301.35 -15.63 9.92 24.08 45.97 -155.09 58.73 23.94 9.57
Pre Tax Margin(%) 6.06 -35.95 -316.31 -15.83 9.86 23.83 24.3 -241.16 -2.34 23.83 9.18
PAT Margin (%) 4.43 -27.76 -307.08 -15.54 5.73 23.6 33.78 -268.67 -13.24 23.81 9.2
Cash Profit Margin (%) 8.54 -0.77 -261.04 -5.82 18.47 43.27 54.88 -177.74 106.31 24.1 9.86
ROA(%) 0.05 -0.11 -4.61 -1.05 0.54 3.36 3.78 -7.19 -0.16 15.78 0.35
ROE(%) 0.09 -0.17 -7.08 -1.51 0.76 5.01 5.83 -11.73 -0.25 20.24 0.43
ROCE(%) 0.41 0.34 -5.99 -1.31 1.12 4.12 6.1 -5.14 0.93 20.35 0.45
Receivable days 0 0 0 0 14.27 15.14 34.74 146.98 0 297.29 5248.74
Inventory Days 0 0 0 58.46 31.88 28.15 52.32 0 0 0 0
Payable days 0 0 0 18.69 70.53 44.49 -183.03 231.43 3716 70.37 0
PER(x) 0 0 0 0 0 0 0 0 0 0 698.39
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 2.99
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 35.27 119.7 34.81 8.51 6.38 4.53 5.31 22.06 43.25 1.11 64.19
EV/Core EBITDA(x) 129.66 132.87 -13.63 -144.05 33.44 10.35 7.92 -34.38 -10.4 3.26 627.44
Net Sales Growth(%) 200.58 -65.16 259 304.76 34.71 65.7 -14.06 -75.42 -66.09 3758.23 -93.94
EBIT Growth(%) 455.78 -4.81 -1814.64 79 185.52 301.97 64.09 -182.93 112.84 1472.77 -97.58
PAT Growth(%) 204.52 -318.47 -3871.58 79.52 149.71 582 23.01 -295.48 98.33 7040.47 -97.66
EPS Growth(%) 0 0 0 0 0 0 0 -295.48 98.33 7035.62 -97.66
Debt/Equity(x) 0.15 0.15 0.16 0.17 0.17 0.31 0.29 0.34 0 0 0
Current Ratio(x) 5.39 3.46 0.32 0.26 0.06 4.14 0.53 0.19 5.31 2.89 3.68
Quick Ratio(x) 5.39 3.46 0.32 0.17 0.04 2.51 0.36 0.19 5.31 2.89 3.68
Interest Cover(x) 1.36 0.64 -20.15 -79.84 144.28 96.99 2.12 -1.8 0.96 225.3 24.4
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Genomic Valley Shareholding Pattern

# Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Promoter 67.85 67.18 67.18 66.32 65.04 64.2 64.14 54.67 46.83 46.78
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 32.15 32.82 32.82 33.68 34.96 35.8 35.86 45.33 53.17 53.22
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 70.37 to 0days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 46.78%.
  • Company has a low return on equity of 7% over the last 3 years.
  • Stock is trading at 3.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Genomic Valley News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!